Protagonist Therapeutics

-$0.40 (-1.31%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell PTGX and other stocks, options, and ETFs commission-free!

About PTGX

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline include PTG-300, PTG-200, and PN-943 The company was founded by Mark L.

CEO
Dinesh V. Patel
Employees
79
Headquarters
Newark, California
Founded
2006

PTGX Key Statistics

Market Cap
1.34B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
314.90K
High Today
$30.71
Low Today
$29.30
Open Price
$30.64
Volume
141.05K
52 Week High
$32.10
52 Week Low
$14.16

PTGX Earnings

-$0.72
-$0.48
-$0.24
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.57 per share
Actual
-$0.54 per share

You May Also Like

HYLD
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure